Polypeptide diet cosmetics products and inter.
Finished Drugs
Nucleosides series
New inhibitors and intermediates
Cardiovascular&Antidiabetic API and intermediates
Anti-tumor and cancer API and intermediates
Antibiotics APIs and intermediates
Antipsychotic API and intermediates
Anti-virus API and intermediates
Dermopathic API and intermediates
Histamine API and intermediates
Respiratory drugs and intermediates
Gastrointestinal stromal API and intermediates
Vitamin Amino acids and nutraceuticals series
Steroid hormones and other intermediates
PVP Homopolymers and special chemicals
Pyridine derivatives agrochem and dyes inter.
Pharmaceutical Excipients
XINXIANG BEST PHARMACEUTICAL CO.,LTD. Sales email：sales@bstpharm.com OEM email：research@bstpharm.com Purchase＆import email：purchase@bstpharm.com Tel：0086-15893897722 Fax：0086-373-3809550 Website：www.bstpharm.com www.xxbestpharm.com Address：1111,BLOCK G1,JINYU BLUE BAY,NO.318 FENGHUA STREET,XINXIANG HIGH-TECH ZONE,HENAN PROVINCE,CHINA 453000
| No | Name | Standard | CAS NO | Remarks |
|---|---|---|---|---|
| XOOO16 | Regorafenib | 99.0% | 755037-03-7 | Anti-cancer API |
| XOOO17 | Regorafenib hydrate | 99.0% | 1019206-88-2 | Anti-cancer API |
| XOOO18 | 5-amino-2-chlorobenzotrifluoride | 99.0% | 320-51-4 | Regorafenib Intermediate |
| XOOO19 | 4-amino-3-fluorophenol | 99.0% | 399-95-1 | Regorafenib Intermediate |
| XOOO20 | 4-(4-Amino-3-fluorophenoxy)pyridine-2-carboxylic acid methylamide | 99.0% | 757251-39-1 | Regorafenib Intermediate |
| S001 | 2-(chloromethyl)-4-methylquinazoline | 99.0% | 109113-72-6 | Linagliptin inter |
| S002 | 8-bromo-3-methyl-3,7-dihydro-1H-purine-2,6-dione | 99.0% | 93703-24-3 | Linagliptin inter |
| S003 | 1-BROMO-2-BUTYNE | 99.0% | 3355-28-0 | Linagliptin inter |
| S004 | 1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine | 99.0% | 1006614-49-8 | Linagliptin inter |
| S005 | 8-bromo-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione | 99.0% | 853029-57-9 | Linagliptin inter |
| S006 | tert-butyl (3R)-piperidin-3-ylcarbamate | 99.0% | 309956-78-3 | Linagliptin inter |
| S007 | (R)-3-aminopiperidine dihydrochloride | 99.0% | 334618-23-4 | Linagliptin inter |
| S008 | Linagliptin | 99.0% | 668270-12-0 | API |
| S009 | 3-Methylamino-1-phenylpropanol | 99.0% | 42142-52-9 | Fluoxetine and Atomoxetine inter |
| S010 | Fluoxetine hydrochloride | 99.0% | 56296-78-7 | Fluoxetine and Atomoxetine inter |
| S011 | N-(Triphenylmethyl)-5-(4-bromomethylbiphenyl-2-yl)tetrazole | 99.0% | 124750-51-2 | Sartans intermediate |
| S012 | 2-Indanone | 99.0% | 615-13-4 | Delapril inter |
| S013 | Eprosartan | 99.0% | 133040-01-4 | R&D |
| S014 | Olmesartan medoxomil | 99.0% | 144689-78-1 | API |
| S015 | Dronedarone & its intermediates | 99.0% | 141625-93-6 | API&INTERS |
| S016 | 4-Chloro-3-nitrobenzoic Acid | 99.0% | 96-99-1 | Dabigatran etexilate mesylate inter |
| S017 | 4-Methylamino-3-nitrobenzoic acid | 99.0% | 41263-74-5 | Dabigatran etexilate mesylate inter. |
| S018 | 4-(methylamino)-3-nitrobenzoyl chloride | 99.0% | 82357-48-0 | C8H7ClN2O3 |
| S019 | Ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate | 99.0% | 429659-01-8 | Dabigatran etexilate mesylate inter. |
| S020 | 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester | 99.0% | 212322-56-0 | C18H22N4O3 |
| S021 | Prasugrel | 99.0% | 150322-43-3 | API |
| S022 | Rivaroxaban | 99.0% | 366789-02-8 | API |
| S023 | 4-(4-Aminophenyl)morpholin-3-one | 99.0% | 438056-69-0 | Rivaroxaban inter. |
| S024 | S)-(+)-N-(2,3-Epoxypropyl) Phthalimide | 99.0% | 161596-47-0 | Rivaroxaban inter |
| S025 | 5-Chlorothiophene-2-carbonylchloride | 99.0% | 42518-98-9 | Rivaroxaban inter. |